Recent News

• 12.03.2025 - BioNTech erfüllt Mindestannahmebedingungen im Rahmen des Umtauschangebots für CureVac-Aktien
• 11.26.2025 - [English only] CureVac Announces Voting Results of Extraordinary General Meeting
• 11.24.2025 - CureVac veröffentlicht Finanzergebnisse für das dritte Quartal und die ersten neun Monate 2025 und informiert über die Geschäftsentwicklung

Recent Filings

• 12.03.2025 - SC TO-T/A Tender offer statement by Third Party
• 12.03.2025 - 425 Prospectuses and communications, business combinations
• 11.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.26.2025 - 425 Prospectuses and communications, business combinations
• 11.26.2025 - EX-99.1 EX-99.1
• 11.26.2025 - SC 14D9/A Solicitation, recommendation statements
• 11.26.2025 - SC TO-T/A Tender offer statement by Third Party
• 11.25.2025 - SC 14D9/A Solicitation, recommendation statements
• 11.24.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.24.2025 - EX-99.1 EX-99.1